SCHEMBL48682

SCHEMBL48682

O[C@H]1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48737 1.00
SCHEMBL17183 1.00
Water SCHEMBL27590110 0.97
Hydrochloric Acid SCHEMBL16919 0.97
Hydrochloric Acid SCHEMBL221709 0.97
Hydrochloric Acid SCHEMBL15018351 0.97
Methane SCHEMBL17043017 0.97
Hydrochloric Acid SCHEMBL322098 0.97
Hydrochloric Acid SCHEMBL23163951 0.94
Ethane SCHEMBL10435359 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4521 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630425-A1 A PROCESS FOR PREPARING PURE (3S)-PYRROLIDIN-3-OL AND PURE (3S)-PYRROLIDIN-3-OL HYDROCHLORIDE Bayer Consumer Care AG (CH) 2025-10-15 EP claimed
EP-4532014-A1 HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 Cerevance, Inc. (US) 2025-04-09 EP claimed
WO-2024121219-A1 A PROCESS FOR PREPARING PURE (3S)-PYRROLIDIN-3-OL AND PURE (3S)-PYRROLIDIN-3-OL HYDROCHLORIDE BAYER CONSUMER CARE AG (CH) 2024-06-13 WO claimed
EP-4382529-A1 A PROCESS FOR PREPARING PURE (3S)-PYRROLIDIN-3-OL AND PURE (3S)-PYRROLIDIN-3-OL HYDROCHLORIDE Bayer Consumer Care AG (CH) 2024-06-12 EP claimed
EP-4330392-A1 TRANSMEMBRANE PROTEASE, SERINE 6 (TMPRSS6) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Alnylam Pharmaceuticals, Inc. (US) 2024-03-06 EP claimed
WO-2023227867-A1 HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 Cerevance, Inc. (US) 2023-11-30 WO claimed
EP-4211116-A1 NOVEL HETEROCYCLIC ANTIBIOTICS F. Hoffmann-La Roche AG (CH) 2023-07-19 EP claimed
CN-115160310-B Alternanthene derivatives as CDK2/Topo I inhibitors, preparation method thereof and antitumor application thereof 中国人民解放军北部战区总医院 2023-06-23 CN claimed
CN-113493628-B Quantum dot ink and preparation method of quantum dot film TCL科技集团股份有限公司 2023-06-23 CN claimed
WO-2022231999-A1 TRANSMEMBRANE PROTEASE, SERINE 6 (TMPRSS6) IRNA COMPOSITIONS AND METHODS OF USE THEREOF ALNYLAM PHARMACEUTICALS, INC. (US) 2022-11-03 WO claimed
WO-2007076158-A2 PROCESSES FOR PREPARING DARIFENACIN HYDROBROMIDE TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2007-07-05 WO claimed
WO-2007011162-A1 SYNTHETIC METHOD OF OPTICALLY PURE (S)-3-HYDROXYPYRROLIDINE CHIROAD INCORPORATE (KR) 2007-01-25 WO claimed
US-20060094880-A9 Synthetic process for trans-aminocyclohexyl ether compounds BARRETT ANTHONY G M 2006-05-04 US claimed
WO-2005016242-A2 SYNTHETIC PROCESS FOR TRANS-AMINOCYCLOHEXYL ETHER COMPOUNDS CARDIOME PHARMA CORP. (CA) 2005-02-24 WO claimed
US-20050038256-A1 Synthetic process for trans-aminocyclohexyl ether compounds CARDIOME PHARMA CORP. (CA) 2005-02-17 US claimed
US-6344566-B1 AMIDATION AND REDUCTION AND CONVERSION WITH ACID; ASIMADOLINE MERCK PATENT GMBH (DE) 2002-02-05 US claimed
US-6143932-A FOR EFFECTING ANALGESIA, A DECREASE IN THE POSTPRANDIAL RISE IN THE BLOOD GLUCOSE LEVELS OF A MAMMAL AFTER INGESTION OF A CARBOHYDRATE LOAD BY SAID MAMMAL, AND TREATING MICROBIAL INFECTIONS TREGA BIOSCIENCES, INC. (US) 2000-11-07 US claimed
EP-0890101-A4 SELECTIVELY N-ALKYLATED PEPTIDOMIMETIC COMBINATORIAL LIBRARIES AND COMPOUNDS THEREIN TORREY PINES INST (US) 1999-12-08 EP claimed
EP-0890101-A1 SELECTIVELY N-ALKYLATED PEPTIDOMIMETIC COMBINATORIAL LIBRARIES AND COMPOUNDS THEREIN TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) 1999-01-13 EP claimed
WO-1997033174-A1 SELECTIVELY N-ALKYLATED PEPTIDOMIMETIC COMBINATORIAL LIBRARIES AND COMPOUNDS THEREIN TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) 1997-09-12 WO claimed